{"name": "BIOMOL International",
 "permalink": "biomol-international",
 "crunchbase_url": "http://www.crunchbase.com/company/biomol-international",
 "homepage_url": "http://www.biomol.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1983,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info-usa@enzolifesciences.com",
 "phone_number": "610-941-0430",
 "description": "",
 "created_at": "Thu Sep 10 01:36:47 UTC 2009",
 "updated_at": "Thu Sep 10 01:36:47 UTC 2009",
 "overview": "\u003Cp\u003EBIOMOL International, LP engages in the research, development, and production of reagents for biomedical research. It offers specialty biochemicals; drug discovery kits, bulk enzymes, and substrates for inhibitor screening of therapeutic targets; and compound libraries for receptor de-orphaning, assay development, and chemical genomics. The company provides products in the areas of signal transduction, lipid signaling, post translational modifications, proteolysis, ubiquitons and zomes, and neuroscience. It also offers custom services for drug discovery programs. BIOMOL International, LP provides its products through an online catalog, as well as through distributors in Africa, Asia, Australia, Central America, Europe, the Middle East, North America, South America, and the United Kingdom. The company was founded in 1983 and is based in Plymouth Meeting, Pennsylvania. It has production facilities in the Greater Philadelphia region; and Exeter, the United Kingdom. As of May 8, 2008, BIOMOL International, LP operates as a subsidiary of Enzo Life Sciences, Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       61],
      "assets/images/resized/0005/9312/59312v1-max-150x150.png"],
     [[240,
       99],
      "assets/images/resized/0005/9312/59312v1-max-250x250.png"],
     [[240,
       99],
      "assets/images/resized/0005/9312/59312v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President",
    "person":
     {"first_name": "Robert",
      "last_name": "Zipkin",
      "permalink": "robert-zipkin",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 23140000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.highbeam.com/doc/1G1-178791370.html",
   "source_description": "Enzo Biochem Acquires BIOMOL International",
   "acquired_year": 2008,
   "acquired_month": 8,
   "acquired_day": 5,
   "acquiring_company":
    {"name": "Enzo Life Sciences",
     "permalink": "enzo-life-sciences",
     "image":
      {"available_sizes":
        [[[150,
           101],
          "assets/images/resized/0005/9313/59313v1-max-150x150.png"],
         [[190,
           129],
          "assets/images/resized/0005/9313/59313v1-max-250x250.png"],
         [[190,
           129],
          "assets/images/resized/0005/9313/59313v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5120 Butler Pike",
    "address2": "Plymouth Meeting",
    "zip_code": "19462",
    "city": "",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}